SERIMMUNE INC.

Profile

Company Names

SERIMMUNE INC.

Addresses

150 CASTILIAN DRIVE, SUITE 100, GOLETA, CA 93117

917 N. PATTERSON AVE., SANTA BARBARA, CA 93111

Phone Numbers

(805) 680-9178
(805) 451-5083

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2014

State Incorporated:

DELAWARE

Total Amount Raised:

$51,977,553.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2023-10-31 
$11,512,176.00 
$16,500,000.00 
$4,987,824.00 
Debt 
6
2023-07-24 
$10,612,176.00 
$15,000,000.00 
$4,387,824.00 
Debt 
5
2021-07-21 
$9,535,454.00 
$13,500,000.00 
$3,964,546.00 
Debt 
4
2021-07-02 
$4,362,861.00 
$7,000,000.00 
$2,637,139.00 
Debt 
3
2020-08-27 
$12,048,253.00 
$23,312,065.00 
$11,263,812.00 
Equity 
2
2019-05-22 
$1,406,111.00 
$7,000,000.00 
$5,593,889.00 
Debt 
1
2016-12-21 
$2,500,522.00 
$8,000,000.00 
$5,499,478.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
PATRICK 
 
DAUGHERTY 
EXECUTIVE OFFICER, DIRECTOR
SERIMMUNE INC.
MALEK 
 
FAHAM 
EXECUTIVE OFFICER, DIRECTOR
MLC DX INC   |  SEQUENTA, INC.   |  SERIMMUNE INC.   |  PROTILLION BIOSCIENCES, LNC.
STEPHEN 
M. 
KUJAWA 
EXECUTIVE OFFICER
SERIMMUNE INC.
KIRSTIN 
 
LOOMIS 
DIRECTOR
SERIMMUNE INC.
KRISTIN 
 
LOOMIS 
EXECUTIVE OFFICER, DIRECTOR
SERIMMUNE INC.   |  BIOPROTONICS, INC.
NICHOLAS 
 
NACLERIO 
DIRECTOR
BOREAL GENOMICS INC.   |  ILLUMINA INNOVATION FUND I, L.P.   |  BAEBIES INC.   |  GENOME MEDICAL HOLDING CO   |  SERIMMUNE INC.   |  PATTERN BIOSCIENCE, INC.   |  ILLUMINA INNOVATION FUND II, L.P.   |  MMMLY INC.   |  ILLUMINA INNOVATION FUND III, L.P.
NICK 
 
NACLERIO 
DIRECTOR
TWIST BIOSCIENCE CORP   |  SERIMMUNE INC.
NOAH 
 
NASSER 
EXECUTIVE OFFICER, DIRECTOR
SERIMMUNE INC.   |  3HELIX, INC.   |  DATMA, INC.
JAYMIE 
R. 
SAWYER 
EXECUTIVE OFFICER
SERIMMUNE INC.
JOHN 
 
SHON 
EXECUTIVE OFFICER
SERIMMUNE INC.
BILL 
 
WELCH 
DIRECTOR
SERIMMUNE INC.   |  AERAMI THERAPEUTICS HOLDINGS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-11-15
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2023-10-31 
2023-08-21
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2023-07-24 
2022-12-01
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2021-07-21 
2022-07-12
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2021-07-21 
2021-08-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2021-07-02 
2020-09-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-08-27 
2019-06-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2019-05-22 
2017-01-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-12-21 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#